28.5 C
New York
Thursday, June 18, 2026

Tag: link

newssourceFORcompanyinformationcontent1marketreleases

RADCOM Delivers 19% YoY Revenue Growth and Margin Expansion in the Second Quarter of 2025

Continued Growth and Improved Profitability Reinforce Full-Year Outlook TEL AVIV, Israel, Aug. 13, 2025 /PRNewswire/ -- RADCOM Ltd (Nasdaq: RDCM) announced today its financial results for...

COLGATE DENTAL VEER ANTHEM LAUNCHED TO EMPOWER KIDS TO BE THEIR OWN HEROES OF ORAL HEALTH

Released close to Independence Day, the anthem is penned by lyricist Swanand Kirkire and composed by Micu Patel Link to the anthem - Colgate Dental...

Invitation to Paratus’ Q2 2025 Earnings Call

HAMILTON, Bermuda, Aug. 13, 2025 /PRNewswire/ -- Paratus Energy Services Ltd. (ticker "PLSV") ("Paratus" or the "Company") will release its unaudited interim Q2 and Half-year...

AB Akola Group will hold an Investor Webinar to introduce the financial results for the 12 months of financial year 2024/2025

AB Akola Group, company code: 148030011, address of the head office: Subaciaus str. 5, LT-01302 Vilnius, Lithuania.

Invitation to Paratus’ Q2 2025 Earnings Call

HAMILTON, Bermuda, Aug. 13, 2025 /PRNewswire/ -- Paratus Energy Services Ltd. (ticker "PLSV") ("Paratus" or the "Company") will release its unaudited interim Q2 and Half-year...

Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity

Greywolf starts first trial of GRWD0715, aiming for a functional cure for autoimmunity by targeting its antigenic source.

Santhera Secures Agreement with GEN for the Distribution of AGAMREE® (Vamorolone) in Türkiye

Pratteln, Switzerland, 13 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) for the distribution and promotion of AGAMREE® (vamorolone) in Türkiye for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age and older.

The Executive Leadership Institute At Clark Atlanta University Opens Applications For 2026 Cohort

Ground-breaking program enters sixth year, propelled by strategic partnerships and strong record of elevating more than 170 emerging presidents and C-suite leaders at Historically...

Enoki Mushroom recalled due to Listeria monocytogenes

OTTAWA, ON, Aug. 12, 2025 /CNW/ - Product: Enoki Mushroom Issue: Food - Microbial contamination - Listeria Distribution Nova Scotia Ontario Quebec Online link SOURCE Canadian Food Inspection Agency (CFIA)

Cavvy Releases Q2 2025 Financial and Operating Results

Third Party Processing Growth and Strong Hedging Gain Bolsters Cash Flow, Drives Debt Reduction 
Third Party Processing Growth and Strong Hedging Gain Bolsters Cash Flow, Drives Debt Reduction

TWFG Announces Second Quarter 2025 Results

– Total Revenues increased 13.8% for the quarter over the prior year period to $60.3 million –
– Total Written Premium increased 14.4% for the quarter over the prior year period to $450.3 million –
– Organic Revenue Growth Rate* of 10.6% for the quarter –
– Net income of $9.0 million for the quarter –
– Adjusted EBITDA* increased 40.7% for the quarter over the prior year period to $15.1 million –

Peyto Reports Second Quarter 2025 Results

CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) --  Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto" or the "Company") is pleased to report operating and financial results for the second quarter of 2025.

Mountain Province Diamonds Announces Second Quarter Financial Results for 2025

TSX: MPVD TORONTO, Aug. 12, 2025 /PRNewswire/ - Mountain Province Diamonds Inc. ("Mountain Province", the "Company") (TSX: MPVD) today announces financial results for the second quarter...

Mountain Province Diamonds Announces Second Quarter Financial Results for 2025

TSX: MPVD TORONTO, Aug. 12, 2025 /PRNewswire/ -- Mountain Province Diamonds Inc. ("Mountain Province", the "Company") (TSX: MPVD) today announces financial results for the second quarter...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLink

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers